Evidence map›Paper›PMID 42545580›Full record

ArticleArchives of orthopaedic and trauma surgery2026

Short- to mid-term clinical outcomes and return to sport and work after arthroscopic debridement of the extensor carpi radialis brevis in patients with chronic lateral epicondylopathy.

Sebastian Siebenlist, Alexandros Doucas, Franziska L Hatt, Sebastian Lappen, Romed P Vieider, Lucca Lacheta, Pavel Kadantsev

Abstract read
In one paragraph

Article in Archives of orthopaedic and trauma surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sebastian SiebenlistDepartment of Sport Orthopaedics, Rechts der Isar Hospital, Munich, Germany. sebastian.siebenlist@mri.tum.de.ORCID https://orcid.org/0000-0002-4777-3639
Alexandros DoucasDepartment of Sport Orthopaedics, Rechts der Isar Hospital, Munich, Germany.
Franziska L HattDepartment of Sport Orthopaedics, Rechts der Isar Hospital, Munich, Germany.
Sebastian LappenDepartment of Sport Orthopaedics, Rechts der Isar Hospital, Munich, Germany.
Romed P VieiderDepartment of Sport Orthopaedics, Rechts der Isar Hospital, Munich, Germany.
Lucca LachetaDepartment of Sport Orthopaedics, Rechts der Isar Hospital, Munich, Germany.
Pavel KadantsevDepartment of Sport Orthopaedics, Rechts der Isar Hospital, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to evaluate the short- to mid-term clinical outcomes following arthroscopic extensor carpi radialis brevis (ECRB) debridement in patients with chronic epicondylopathy humeri radialis (cEHR). We hypothesized that arthroscopic ECRB debridement would result in favorable short- to mid-term patient-reported outcomes, improving pain levels, strength, range of motion (ROM) and patient satisfaction.

methodsA retrospective case series was conducted on patients who underwent arthroscopic ECRB debridement for cEHR with symptoms > 6 months. Patients were assessed at a minimum of 12 months postoperatively using the Mayo Elbow Performance Score (MEPS), Patient-Rated Tennis Elbow Evaluation (PRTEE), Disabilities of the Arm, Shoulder, and Hand (DASH) score, and Visual Analog Scale (VAS) for pain. Pre- and postoperative scores were compared using DASH and VAS. Maximum isometric wrist extension strength and postoperative ROM were measured bilaterally. Return to sport and work, patient satisfaction, and complications were documented.

resultsOf the 35 eligible patients, 30 completed follow-up (86% follow-up rate; mean age 48.4 ± 6.6 years; range: 36-65 years; 47% male). The mean duration of symptoms before surgery was 12 months (IQR 8-20, range 6-62). The mean follow-up duration was 28.13 ± 10.9 months (range 12-45). At final follow-up, median outcome scores were 100 (IQR 100-100; range 65-100) for the MEPS, 8.7 (IQR 0.8-13.9; range 0-39.2) for the DASH, 0 (IQR 0-1; range 0-7) for the VAS and 10.3 (IQR 0.8-26.8; 0-79.5) for the PRTEE. In comparison to preoperative values, VAS scores significantly improved (6 [IQR 2.75-7, range 9] vs. 0 [IQR 0-1, range 0-7], p < 0.01), as did DASH scores (46.6 ± 20 vs. 10.3 ± 10.5, p < 0.01). Post-operatively, all patients recovered full range of motion, with an arc of at least 140°. The median wrist extension strength in the operated arm was 98.6% (IQR: 87.4-107%, range: 69.5-121%) when compared to the healthy side, with no significant differences (p = 0.681). Overall, 80% of patients returned to sports at the same or a slightly reduced level, including 12% who achieved a higher activity level than before. The vast majority of patients (97%) successfully returned to their previous professional activities, while only a small proportion (3%) retired from a part-time manual labor position post-surgery, primarily due to age. Furthermore, 83% of patients indicated they would undergo the procedure again. One patient developed posterolateral rotational instability six months after index surgery and consequently required reconstruction of the lateral ulnar collateral ligament (LUCL).

conclusionArthroscopic ECRB debridement for cEHR was associated with improved pain and function and high rates of return to sport and work at short- to mid-term follow-up. LEVEL OF EVIDENCE: IV Retrospective case series.

Indexed as

ArthroscopyDebridementReturn to SportReturn to WorkTennis ElbowAdultAgedChronic DiseaseFemaleHumansMaleMiddle AgedPain MeasurementPatient SatisfactionRange of Motion, ArticularRetrospective StudiesECRB-debridementElbow arthroscopyExtensor carpi radialis brevis debridementLateral epicondylitisTennis elbow

Identifiers

PMID42545580
PMCPMC13433409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.